FDA Recall of Medtronic MiniMed 700G Insulin Pump for Delivery Issues
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medtronic MiniMed, Inc. is recalling 13,811 units of the MiniMed 700G Insulin Pump due to potential over- or under-delivery of insulin caused by gravitational forces, which could lead to serious health risks.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 16, 2026 and geographically references Worldwide, including United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
The recall involves unintended over- and under-delivery of insulin in Medtronic MiniMed infusion pumps due to changes in gravitational force affecting hydrostatic and hydrodynamic pressures. This can result in severe hypoglycemia, altered mental status, seizure, coma, or death from over-delivery, and severe hyperglycemia, dehydration, diabetic ketoacidosis, or death from under-delivery.
Which Products Are Affected
The affected products are the MiniMed 700G Insulin Pump with model numbers MMT-1801, MMT-1805, MMT-1850, and MMT-1851. A total of 13,811 units are involved. The distribution is worldwide, including US nationwide in states such as OR, CA, AZ, NY, TX, FL, OH, MO, TN, NJ, NC, SC, IL, VA, WA, DC, GA, PA, MS, IA, MI, NH, OK, SD, MT, WI, WV, MA, LA, MN, RI, AR, ME, AL, IN, UT, KY, CO, ND, MD, CT, NM, KS, ID, NV, DE, NE, VT, AK, HI, WY, PR, VI, and various countries. The recall number is Z-1744-2026.
What You Should Do
Consumers who received a letter notification from the firm should follow the instructions provided in that letter regarding the recall.
Why This Matters
This recall addresses a potential life-threatening issue with insulin delivery in medical devices, affecting thousands of users who rely on these pumps for diabetes management.
Source
FDA, Recall Number Z-1744-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,331 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 16, 2026.
Frequently Asked Questions
Common questions about this FDA recall.